Results 221 to 230 of about 6,479,069 (356)

Let Us FIGURE It Out: Why Do Scientists Still Make "Bad" Figures? [PDF]

ACS Mater Au
Rayaroth A, Fiedler C, Ibáñez M.
europepmc   +1 more source

A Process-Oriented Approach to Software Component Definition [PDF]

, 1999
Florian Matthes, Holm Wegner, Patrick Hupe   +2 more
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

A software reliability model for open source big data systems based on Weibull-Weibull distribution. [PDF]

Sci Rep
Wang J, Geng H, Li P.
europepmc   +1 more source

On individual differences in laerning processes of a Japanese word-processing software in case of novice users

, 1990
Mayuka F. Kawaguchi, Kazutoshi MOCHIDZUKI, T. Da-Te   +2 more
openalex   +2 more sources

Applying the personal software process in CS1 [PDF]

, 1998
Lily Hou, James E. Tomayko
openalex   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

Increasing hospital administrative efficiency via optimized office automation systems: A PDCA cycle approach. [PDF]

PLoS One
Lu R, Zhang Y, Luo L, Yuan Q, Chen S, Lv N, Zheng F, Deng G, Ma Y, Xu J, Chen Z, Zhang F.   +11 more
europepmc   +1 more source

Treated effluent disposal system process control computer software requirements and specification

, 1994
François Graf
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source